BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28301622)

  • 1. Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.
    Berman B; Ablon GR; Bhatia ND; Ceilley RI; Goldberg DJ; Nestor MS; Weinkle SH
    J Drugs Dermatol; 2017 Mar; 16(3):260-264. PubMed ID: 28301622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
    Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
    G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
    Lee AD; Jorizzo JL
    Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists.
    Noels EC; Lugtenberg M; van Egmond S; Droger SM; Buis PAJ; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Jul; 181(1):96-104. PubMed ID: 30801664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
    Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity.
    Dréno B; Cerio R; Dirschka T; Nart IF; Lear JT; Peris K; de Casas AR; Kaleci S; Pellacani G
    Acta Derm Venereol; 2017 Oct; 97(9):1108-1113. PubMed ID: 28536731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for actinic keratosis.
    Ulrich M; Drecoll U; Stockfleth E
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential Treatment of Actinic Keratosis and Photoaging by Daylight PDT and Injectable NASHA Gel as Skin Booster.
    Belmontesi M
    J Drugs Dermatol; 2020 Nov; 19(11):1065-1068. PubMed ID: 33196754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
    See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
    Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations.
    Grinblat B; Galimberti G; Chouela E; Sanclemente G; Lopez M; Alcala D; Torezan L; Pantoja G
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):81-7. PubMed ID: 26541910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
    Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core Outcome Set for Actinic Keratosis Clinical Trials.
    Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
    JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
    Puviani M; Barcella A; Milani M
    G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.
    Richard MA; Amici JM; Basset-Seguin N; Claudel JP; Cribier B; Dreno B
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):339-346. PubMed ID: 29235161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: a case-series of 16 patients.
    Hasson A; Navarrete-Dechent C; Nicklas C; de la Cruz C
    Indian J Dermatol Venereol Leprol; 2012; 78(4):448-53. PubMed ID: 22772615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.
    Dréno B; Amici JM; Basset-Seguin N; Cribier B; Claudel JP; Richard MA;
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1141-9. PubMed ID: 24612407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
    Berman B; Cohen DE; Amini S
    Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapies for actinic keratosis.
    Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
    Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Hotline: Facial skin rejuvenation in a patient treated with photodynamic therapy for actinic keratosis.
    Bruscino N; Rossi R; Dindelli M; Ghersetich I; Lotti T
    Dermatol Ther; 2010; 23(1):86-9. PubMed ID: 20136912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial.
    Erlendsson AM; Karmisholt KE; Haak CS; Stender IM; Haedersdal M
    J Am Acad Dermatol; 2016 Apr; 74(4):709-15. PubMed ID: 26810403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.